True about drug induced lupus
**Core Concept**
Drug-induced lupus erythematosus (DILE) is a rare, autoimmune-like condition resulting from long-term exposure to certain medications, particularly those with antihistone reactivity. This condition shares clinical and immunological features with systemic lupus erythematosus (SLE) but has distinct differences in its pathophysiology and clinical manifestations.
**Why the Correct Answer is Right**
The pathogenesis of DILE involves the formation of antihistone antibodies, which are directed against histone proteins in chromatin. This immune response leads to the activation of various immune cells, including T cells and macrophages, resulting in the production of pro-inflammatory cytokines and the development of clinical manifestations. Notably, DILE is more commonly associated with antihistone antibodies than with anti-double-stranded DNA (anti-dsDNA) antibodies, which are characteristic of SLE.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because DILE is not typically characterized by the presence of anti-Sm antibodies, which are highly specific for SLE.
**Option B:** Incorrect because while DILE can present with arthralgias and myalgias, it is not typically associated with the presence of anti-Ro (SS-A) or anti-La (SS-B) antibodies, which are commonly seen in SLE.
**Option C:** Incorrect because DILE is not typically characterized by the presence of renal involvement, such as proteinuria or hematuria, which are common in SLE.
**Option D:** Incorrect because while DILE can present with fever and fatigue, it is not typically associated with the presence of thrombocytopenia or leukopenia, which are common in SLE.
**Clinical Pearl / High-Yield Fact**
A key distinguishing feature of DILE is its association with the use of hydralazine and procainamide, two medications that are well-documented to induce antihistone antibodies in susceptible individuals. This association highlights the importance of considering medication-induced lupus in the differential diagnosis of patients presenting with symptoms suggestive of SLE.
**Correct Answer:** Not provided.